Marketing Intern- FUROSCIX
Burlington, MA (Hybrid)
Salary Not AvailableIntern/New GradIntern
Posted 4 days ago
Job Summary
Original Job Description
MannKind Corporation
MannKind Corporation (Nasdaq: MNKD) is a biopharmaceutical company dedicated to transforming chronic disease care through innovative, patient-centric solutions. Focused on cardiometabolic and orphan lung diseases, we develop and commercialize treatments that address serious unmet medical needs, including diabetes, pulmonary hypertension, and fluid overload in heart failure and chronic kidney disease.With deep expertise in drug-device combinations, MannKind aims to deliver therapies designed to fit seamlessly into daily life.Please visit mannkindcorp.com to learn more.
Marketing team
22
Employees
803
Headquarters
Danbury, Connecticut, USA
Founded
1991
Employee Sentiment
Overall Rating
3.6 / 5
Recommend to a Friend
79%
CEO Approval
85%
Source: Glassdoor
Traffic Signals
Monthly Visitors
14.4K
Monthly Google Ads Budget
$0.0
Traffic Source Mix
Search
45%
Direct
40.4%
Referral
7.5%
Social
5.6%
Paid
1.4%
Headcount Trend
Current headcount: ~803
Funding
Total Funding
$475.0M
Last Raise
7 months ago
Last Raise Amount
$75.0M
- 2025-08-06Post IPO Debt • $75.0M
- 2021-03-02Post IPO Debt • $200.0M
- 2018-12-01Post IPO Equity • $40.0M
Recent News
MarketBeat
MannKind Corporation (NASDAQ:MNKD) Given Average Recommendation of "Moderate Buy" by Brokerages
Nov 21, 2025
newser.com
Is MannKind Corporation (NNFN) stock attractive post correction - 2025 Market WrapUp & Accurate Buy Signal Alerts
Nov 21, 2025
newser.com
What momentum indicators show for MannKind Corporation stock - Wall Street Watch & Expert Curated Trade Ideas
Nov 19, 2025
newser.com
What momentum indicators show for MannKind Corporation stock - July 2025 Institutional & Verified Swing Trading Watchlist
Nov 19, 2025
newser.com
Can swing trading help recover from MannKind Corporation losses
Nov 16, 2025
newser.com
Is MannKind Corporation stock attractive for retirement portfolios - Market Risk Analysis & Risk Controlled Swing Alerts
Nov 16, 2025
MarketBeat
Connor Clark & Lunn Investment Management Ltd. Decreases Position in MannKind Corporation $MNKD
Nov 15, 2025
newser.com
How MannKind Corporation stock responds to policy changes - Portfolio Return Summary & Long-Term Capital Growth Ideas
Nov 14, 2025
MarketBeat
Los Angeles Capital Management LLC Buys 177,440 Shares of MannKind Corporation $MNKD
Nov 12, 2025
Yahoo Finance
MannKind to Present at the Jefferies Global Healthcare Conference
Nov 11, 2025
Yahoo Finance
MannKind Corp (MNKD) Q3 2025 Earnings Call Highlights: Record Revenue and Strategic Expansions ...
Nov 8, 2025
Sahm
Revenue Jump and Portfolio Expansion Could Be a Game Changer for MannKind (MNKD)
Nov 7, 2025
TradingView
MANNKIND CORP SEC 10-Q Report
Nov 5, 2025
Yahoo Finance
MannKind (MNKD) Reports Q3 Earnings: What Key Metrics Have to Say
Nov 5, 2025
MarketBeat
Simon Quick Advisors LLC Acquires Shares of 48,216 MannKind Corporation $MNKD
Nov 5, 2025
MarketBeat
MannKind Corporation (NASDAQ:MNKD) Short Interest Up 37.4% in October
Nov 4, 2025
Yahoo Finance
MannKind Corp (MNKD) Q3 2025 Earnings Report Preview: What to Expect
Nov 4, 2025
Yahoo Finance
MannKind Corporation to Hold 2025 Third Quarter Financial Results Conference Call on November 5, 2025
Oct 29, 2025
Quiver Quantitative
MannKind Corporation to Announce Q3 2025 Financial Results and Host Webcast on November 5, 2025
Oct 29, 2025
MarketBeat
MannKind Corporation (NASDAQ:MNKD) Receives Average Recommendation of "Moderate Buy" from Brokerages
Oct 27, 2025
newser.com
How analysts rate MannKind Corporation stock today - July 2025 Recap & Safe Capital Growth Stock Tips
Oct 23, 2025
newser.com
How MannKind Corporation stock responds to policy changes - Weekly Trend Summary & Comprehensive Market Scan Insights
Oct 23, 2025
newser.com
How MannKind Corporation stock responds to policy changes - Market Activity Report & Consistent Profit Trading Strategies
Oct 21, 2025
nchmf.gov.vn
Is MannKind Corporation (NNFN) stock attractive post correction - 2025 Pullback Review & Weekly Return Optimization Alerts
Oct 20, 2025
newser.com
Is MannKind Corporation (NNFN) stock attractive post correction - Profit Target & Verified Stock Trade Ideas
Oct 20, 2025
nchmf.gov.vn
Earnings Beat: Is MannKind Corporation stock vulnerable to regulatory risks - Market Growth Summary & Reliable Price Action Trade Plans
Oct 18, 2025
nchmf.gov.vn
Will MannKind Corporation stock remain a Wall Street favorite - 2025 Buyback Activity & AI Forecast Swing Trade Picks
Oct 17, 2025
nchmf.gov.vn
Portfolio Shifts: Will MannKind Corporation stock remain a Wall Street favorite - Market Activity Report & Technical Buy Zone Confirmation
Oct 17, 2025
Seeking Alpha
MannKind: Durable Cash Engine, Optional Catalysts Pending (NASDAQ:MNKD)
Oct 15, 2025
Sahm
MannKind (MNKD) Is Down 9.9% After FDA Reviews Afrezza for Pediatric Use Will Growth Prospects Shift?
Oct 14, 2025
Yahoo Finance
MannKind Announces U.S. FDA Accepts for Review its Supplemental Biologics License Application (sBLA) for Inhaled Insulin (Afrezza) in Children and Adolescents Aged 4-17 Years Living with Diabetes
Oct 13, 2025
GlobeNewswire
MannKind Announces U.S. FDA Accepts for Review its Supplemental Biologics License Application (sBLA) for Inhaled Insulin (Afrezza) in Children and Adolescents Aged 4-17 Years Living with Diabetes
Oct 13, 2025
Quiver Quantitative
MannKind Corporation Submits Supplemental Biologics License Application for Needle-Free Afrezza Inhalation Powder for Pediatric Diabetes Treatment
Oct 13, 2025
investing.com
MannKind completes acquisition of scPharmaceuticals in $296.5 million deal
Oct 9, 2025
Quiver Quantitative
MannKind Corporation Completes Acquisition of scPharmaceuticals Inc. to Enhance Growth in Cardiometabolic Care
Oct 7, 2025
Yahoo Finance
MannKind Completes Acquisition of scPharmaceuticals, Accelerating Revenue Growth in Cardiometabolic Care
Oct 7, 2025
Stock Titan
Over $370M Annualized Run Rate — MannKind Completes Acquisition of scPharmaceuticals; $5.35 Cash
Oct 7, 2025
GlobeNewswire
MannKind Appoints Dr. Ajay Ahuja as Executive Vice President and Chief Medical Officer
Sep 29, 2025
GuruFocus
MNKD: HC Wainwright & Co. Reiterates Buy Rating with $11 Target | MNKD Stock News
Sep 18, 2025
Yahoo Finance
H.C. Wainwright Reiterates a Buy Rating on MannKind Corporation (MNKD)
Aug 30, 2025
GlobeNewswire
MannKind Announces Expansion of United Therapeutics Collaboration for Second Inhaled Therapy
Aug 27, 2025
Latham & Watkins LLP
Latham & Watkins Advises scPharmaceuticals in Acquisition by MannKind Corporation
Aug 27, 2025
Insider Monkey
Leerink Partners Reiterates a Buy Rating on MannKind Corporation (MNKD), Keeps the PT at $7
Aug 25, 2025
Yahoo Finance
Leerink Partners Reiterates a Buy Rating on MannKind Corporation (MNKD), Keeps the PT at $7
Aug 25, 2025
Stocktwits
MannKind Corporation to Acquire scPharmaceuticals: More Details Inside
Aug 25, 2025
Yahoo Finance
Leerink Partners Reiterates a Buy on MannKind Corporation (MNKD), Keeps the PT
Aug 22, 2025
Yahoo Finance
MannKind (MNKD) Secures $500M Financing to Advance Inhaled Therapies Pipeline
Aug 17, 2025
Insider Monkey
MannKind Corporation (NASDAQ:MNKD) Q2 2025 Earnings Call Transcript
Aug 7, 2025
WebWire
MannKind and Blackstone Announce up to $500 Million Strategic Financing Agreement
Aug 7, 2025
Nasdaq
MannKind And Blackstone Announce Up To $500 Mln Strategic Financing Agreement
Aug 6, 2025
GlobeNewswire
MannKind Corporation Reports Second Quarter 2025 Financial Results And Provides Business Update
Aug 6, 2025
GuruFocus
MannKind Corporation Reports Second Quarter 2025 Financial Resu
Aug 6, 2025
MannKind
MannKind and Blackstone Announce up to $500 Million Strategic Financing Agreement
Aug 6, 2025
thefly.com
MannKind selloff on earnings overdone, says H.C. Wainwright
Aug 6, 2025
BioSpace
MannKind Corporation Reports Second Quarter 2025 Financial Results And Provides Business Update
Aug 6, 2025
thefly.com
MannKind, Blackstone enter up to $500M strategic financing agreement
Aug 6, 2025
thefly.com
MannKind reports Q2 non-GAAP EPS 5c, consensus 8c
Aug 6, 2025
MarketScreener
MannKind Corporation announced that it expects to receive $200 million in funding from Blackstone Alternative Credit Advisors LP
Aug 6, 2025
BioSpace
MannKind and Blackstone Announce up to $500 Million Strategic Financing Agreement
Aug 6, 2025
MannKind
MannKind Corporation to Hold 2025 Second Quarter Financial Results Conference Call on August 6, 2025
Jul 30, 2025
Yahoo Finance
MannKind Corporation (MNKD) Presented Inhaled Insulin Therapy At American Diabetes Association
Jul 23, 2025
Research and Markets
Nontuberculous Mycobacteria (NTM) Opportunity Assessment and Forecast to 2033 Featuring Janssen, Novartis, Meiji Seika Pharma, Insmed, Daiichi Sankyo, MannKind, Paratek, Nobelpharma, GSK, Pfizer
Jul 17, 2025
thefly.com
MannKind assumed with a Buy at H.C. Wainwright
Jul 16, 2025
MarketScreener
MannKind Corporation(NasdaqGM:MNKD) dropped from Russell Microcap Growth Index
Jun 30, 2025
Yahoo Finance
MannKind (MNKD) Presents Pediatric Insulin Trial Data
Jun 23, 2025
Morningstar.com
Inhaled Insulin Shown as a Safe and Effective Replacement for Standard-of-Care in Children with Type 1 Diabetes
Jun 22, 2025
EIN Presswire
Type 1 Diabetes Market Size to Reach USD 9.6 billion by 2035 | Epidemiology, Treatment, Trends & Rising Incidence
Jun 17, 2025
BioSpace
MannKind to Highlight Data from Recent Pediatric and Adult Studies of Inhaled Insulin (Afrezza®) at American Diabetes Association’s 85th Scientific Sessions in Chicago, June 20-23
Jun 10, 2025
MannKind
MannKind to Highlight Data from Recent Pediatric and Adult Studies of Inhaled Insulin (Afrezza®) at American Diabetes Association’s 85th Scientific Sessions in Chicago, June 20-23
Jun 9, 2025
MannKind
INDYCAR Driver Conor Daly To Share His Personal Diabetes Story and Race Go-Karts With Detroit Area Youth On Thursday, May 29
May 27, 2025
MannKind
MannKind to Present at Upcoming Investor Conferences
May 13, 2025
Yahoo Finance
MannKind Corporation (MNKD): Among the Best Cancer Stocks to Invest in for Long-Term Gain
May 9, 2025
MarketScreener
MannKind's Q1 Adjusted Earnings, Revenue Increase
May 8, 2025
Seeking Alpha
MannKind Non-GAAP EPS of $0.07 beats by $0.01, revenue of $78.35M beats by $2.49M
May 8, 2025
MannKind
MannKind Corporation to Hold 2025 First Quarter Financial Results Conference Call on May 8, 2025
May 1, 2025
BioSpace
MannKind Corporation to Hold 2025 First Quarter Financial Results Conference Call on May 8, 2025
May 1, 2025
Insider Monkey
Is MannKind Corp. (NASDAQ:MNKD) the Best Biotech Penny Stock to Buy According to Hedge Funds?
Apr 16, 2025
Yahoo Finance
Is MannKind Corp. (NASDAQ:MNKD) the Best Biotech Penny Stock to Buy According to Hedge Funds?
Apr 16, 2025
Investing.com
Mizuho sets MannKind stock Outperform with $12 target
Apr 9, 2025
MannKind
MannKind Teams Up with Juncos Hollinger Racing (JHR) Driver Conor Daly to Drive Awareness of Diabetes and Innovative Treatment Options
Apr 7, 2025
Research and Markets
Needle Free Diabetes Care Market Analysis and Forecast 2025-2030 - Closed-Loop Systems Becoming More Accessible, User-Friendly, and Effective
Apr 1, 2025
EIN Presswire
Short Acting Insulin Global Market Report 2025: Projected To Reach $14.47 Billion With A CAGR Of 5.6%
Mar 30, 2025
Investing.com
MannKind at Barclays Healthcare Conference: Strategic Growth and Innovation
Mar 12, 2025
Nasdaq
MannKind Corporation Showcases Positive Outcomes of Inhaled Insulin at ATTD 2025 with Anticipated sNDA Filing for Pediatric Use in 2025
Mar 10, 2025
StockTitan
MannKind Advances Pediatric Inhaled Insulin Program with 5 Clinical Studies
Mar 10, 2025
BioSpace
MannKind Showcases Efficacy, Safety, and Mealtime Control Data from Recent Pediatric and Adult Studies of Afrezza® at the ATTD Conference, March 19-22
Mar 10, 2025
GlobeNewswire News Room
MannKind Showcases Efficacy, Safety, and Mealtime Control Data from Recent Pediatric and Adult Studies of Afrezza® at the ATTD Conference, March 19-22
Mar 10, 2025
GlobeNewswire
MannKind Corporation Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
Feb 26, 2025
Yahoo Finance
MannKind Corp (MNKD) Q4 2024 Earnings Call Highlights: Record Revenue Growth and Strategic ...
Feb 26, 2025
StreetInsider.com
MannKind (MNKD) Files Mixed Shelf
Feb 26, 2025
Seeking Alpha
Mannkind stock gains amid Q4 report, business update
Feb 26, 2025
StreetInsider.com
MannKind (MNKD) Files Mixed Shelf
Feb 26, 2025
BioSpace
MannKind Corporation to Hold 2024 Fourth Quarter and Full Year Financial Results Conference Call on February 26, 2025
Feb 20, 2025
GlobeNewswire News Room
MannKind Corporation to Hold 2024 Fourth Quarter and Full Year Financial Results Conference Call on February 26, 2025
Feb 19, 2025
MarketBeat
Wedbush Initiates Coverage on MannKind (NASDAQ:MNKD) - MarketBeat
Feb 14, 2025
MarketBeat
SG Americas Securities LLC Has $182,000 Holdings in MannKind Co. (NASDAQ:MNKD) - MarketBeat
Feb 12, 2025
Nasdaq
MannKind To Present At Oppenheimer Healthcare Life Sciences Conference; Webcast At 11:20 AM ET - Nasdaq
Feb 11, 2025
Stock Traders Daily
(MNKD) Technical Data - Stock Traders Daily
Feb 11, 2025
Defense World
MannKind (NASDAQ:MNKD) Coverage Initiated by Analysts at Wedbush - Defense World
Feb 11, 2025
MarketBeat
MannKind Co. (NASDAQ:MNKD) Shares Sold by Calamos Advisors LLC - MarketBeat
Feb 9, 2025